Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

US Patent 9301934 · Granted Apr 5, 2016

Estimated economic value: $16,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Topical naloxone compositions and methods for using the same2025
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid2025
Methods of treating idiopathic hypersomnia2024
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid2024
5-hydroxytryptophan gastroretentive dosage forms2023
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders2022
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods 2022
Pharmaceutical formulations2022
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid2022
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modifi2021
Methods and compositions for transdermal delivery of a non-sedative amount of de2021
Methods and compositions for treating attention deficit hyperactivity disorder, 2020